Arbor Surgical Technologies Inc.
This article was originally published in Start Up
Executive Summary
Arbor Surgical Technologies Inc. is gunning for its share of the $1-billion cardiac surgery market with two distinct technologies: a proprietary bovine pericardial heart valve and a unique surgical implantation system, which combine to form a complete platform designed to simplify valve replacement surgery.
You may also be interested in...
Medtronic: Doing Just What the Doctors Order
Medtronic has recruited physician opinion leaders for strategic management positions in most of its operating divisions. The company believes this strategy will help bring them closer to customers and expedite the bedside-to-bench process for developing new products.
Medtronic: Doing Just What the Doctors Order
Medtronic has recruited physician opinion leaders for strategic management positions in most of its operating divisions. The company believes this strategy will help bring them closer to customers and expedite the bedside-to-bench process for developing new products.
In Heart Valves, The End of Watchful Waiting?
Health Research International has just issued a report, "US Opportunities in Heart Valve Disease Management." According to the report, the market for valve replacement and repair products will grow from more than $500 million in 2004 to some $900 million in 2010, with the greatest growth occurring in percutaneous valve products.